COMBINATION THERAPY OF A GPRC5D TCB AND PROTEASOME INHIBITORS

The present invention relates to the combination therapy of anti-GPRC5D/anti-CD3 bispecific antibodies with proteasome inhibitors. The combination therapy may further comprise a glucocorticosteroid. La présente invention concerne la polythérapie combinant des anticorps bispécifiques anti-GPRC5D/anti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JACOB, Wolfgang, UMAÑA, Pablo, ECKMANN, Jan, WEISSER, Martin, FAUTI, Tanja, HAGE, Carina, SCHNEIDER, Meike
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the combination therapy of anti-GPRC5D/anti-CD3 bispecific antibodies with proteasome inhibitors. The combination therapy may further comprise a glucocorticosteroid. La présente invention concerne la polythérapie combinant des anticorps bispécifiques anti-GPRC5D/anti-CD3 et des inhibiteurs du protéasome. La polythérapie peut en outre comprendre un glucocorticostéroïde.